Atorvastatin aminotransferase elevation, should first clarify the specific cause of aminotransferase elevation, to determine whether it is caused by atorvastatin medication, or dyslipidemia itself caused by liver function abnormalities, in order to clarify the discontinuation of the drug or the addition of liver-protecting drugs.
Atorvastatin and other statin lipid-lowering medications carry the risk of elevated aminotransferases, but dyslipidemia itself can also cause liver abnormalities such as elevated aminotransferases.
When elevated transaminases occur after medication use, it is important to determine whether the medication is being taken to cause them. This can be done by looking at the liver function before the medication and the degree of transaminase elevation after the medication. If the liver function is normal before taking the drug, but the transaminase is elevated significantly after taking the drug, even more than twice, the drug should be stopped promptly.
If the aminotransferase is already elevated before the use of the drug, but there is no further elevation of aminotransferase after the use of the drug, and the elevation is less than two times, you can continue to use the drug, and if necessary, add liver-protecting drugs at the same time, and regular review can be done.
If the above symptoms occur, it is recommended to go to the hospital in time for early and regular treatment.